Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme

NCT03047473 is registered in ClinicalTrials.gov with Clinique Neuro-Outaouais as lead sponsor.

NCT NCT03047473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03047473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme
Lead sponsor
Clinique Neuro-Outaouais
Phase
Phase 2
Overall status
Completed
Start date
May 19, 2017
Completion date
August 9, 2021
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme of brain